Skip to content

FUSE MEDICAL, INC.: 10-Q filed 2020-11-16

What FUSE MEDICAL, INC. reported in its quarterly report filed 2020-11-16 (fiscal Q3 2020): 46 published measures, 125 facts as tagged in accession 0001564590-20-054212.

This filing

Form
10-Q (quarterly report)
Filed
2020-11-16
Fiscal period
fiscal Q3 2020
Accession
0001564590-20-054212 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All FUSE MEDICAL, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-09-3016,990,375USD
At 2019-12-3118,381,491USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-09-3019,410,539USD
At 2019-12-3119,603,624USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-09-30-2,420,164USD
At 2019-12-31-1,222,133USD
At 2019-09-30-2,763,281USD
At 2018-12-311,466,684USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-07-01 to 2020-09-3080,484USD92
2020-01-01 to 2020-09-30-1,626,946USD274
2019-07-01 to 2019-09-30-4,064,342USD92
2019-01-01 to 2019-09-30-4,717,489USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-01-01 to 2020-09-30463,084USD274
2019-01-01 to 2019-09-30-88,097USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-09-3020,757USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2020-07-01 to 2020-09-305,738,662USD92
2020-01-01 to 2020-09-3014,385,831USD274
2019-07-01 to 2019-09-305,716,344USD92
2019-01-01 to 2019-09-3015,562,928USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-2,749USD274
2019-01-01 to 2019-09-30275,053USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-20,757USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-09-30-4,222,759USD
At 2019-12-31-2,595,813USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2020-07-01 to 2020-09-3070,221,566shares92
2020-01-01 to 2020-09-3070,221,566shares274
2019-07-01 to 2019-09-3070,221,566shares92
2019-01-01 to 2019-09-3070,221,566shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2020-07-01 to 2020-09-3074,999,458shares92
2020-01-01 to 2020-09-3070,221,566shares274
2019-07-01 to 2019-09-3070,221,566shares92
2019-01-01 to 2019-09-3070,221,566shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2020-07-01 to 2020-09-300USD/shares92
2020-01-01 to 2020-09-30-0.02USD/shares274
2019-07-01 to 2019-09-30-0.06USD/shares92
2019-01-01 to 2019-09-30-0.07USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2020-07-01 to 2020-09-300USD/shares92
2020-01-01 to 2020-09-30-0.02USD/shares274
2019-07-01 to 2019-09-30-0.06USD/shares92
2019-01-01 to 2019-09-30-0.07USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2020-07-01 to 2020-09-305,661USD92
2020-01-01 to 2020-09-3011,341USD274
2019-07-01 to 2019-09-30926,517USD92
2019-01-01 to 2019-09-30771,582USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-09-3025,255USD
At 2019-12-3132,639USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2020-01-01 to 2020-09-30428,915USD274
2019-01-01 to 2019-09-30487,524USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-07-01 to 2020-09-30106,756USD92
2020-01-01 to 2020-09-30-1,539,972USD274
2019-07-01 to 2019-09-30-3,102,925USD92
2019-01-01 to 2019-09-30-3,857,545USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-09-3011,771,832USD
At 2019-12-3114,244,700USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-07-01 to 2020-09-3020,611USD92
2020-01-01 to 2020-09-3075,633USD274
2019-07-01 to 2019-09-3034,900USD92
2019-01-01 to 2019-09-3088,362USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-09-307,415,174USD
At 2019-12-317,958,259USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-09-302,343,483USD
At 2019-12-312,752,854USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2020-09-301,972,886USD
At 2019-12-311,972,886USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2020-09-303,215,069USD
At 2019-12-315,249,653USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,588,184USD92
2020-01-01 to 2020-09-3010,102,522USD274
2019-07-01 to 2019-09-304,031,330USD92
2019-01-01 to 2019-09-3010,433,277USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2020-09-306,982,916USD
At 2019-12-317,855,887USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2020-07-01 to 2020-09-303,694,940USD92
2020-01-01 to 2020-09-308,562,550USD274
2019-07-01 to 2019-09-30928,405USD92
2019-01-01 to 2019-09-306,575,732USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2020-07-01 to 2020-09-302,043,722USD92
2020-01-01 to 2020-09-305,823,281USD274
2019-07-01 to 2019-09-304,787,939USD92
2019-01-01 to 2019-09-308,987,196USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2020-07-01 to 2020-09-301,379,385USD92
2020-01-01 to 2020-09-305,021,632USD274
2019-07-01 to 2019-09-302,263,964USD92
2019-01-01 to 2019-09-306,604,066USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-09-3073,124,458shares
At 2019-12-3173,124,458shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-09-3065,744USD
At 2019-12-3171,636USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-09-3040,489USD
At 2019-12-3138,997USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-09-301,150,713USD
At 2019-12-311,206,620USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-09-303,521,939USD
At 2019-12-313,302,904USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2020-09-3034,959USD
At 2019-12-3139,850USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-1,626,946USD274
2019-01-01 to 2019-09-30-4,717,489USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-07-01 to 2020-09-308,116USD92
2020-01-01 to 2020-09-3028,141USD274
2019-07-01 to 2019-09-305,241USD92
2019-01-01 to 2019-09-3015,851USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2020-07-01 to 2020-09-3023,312USD92
2020-01-01 to 2020-09-3084,047USD274
2019-07-01 to 2019-09-3025,596USD92
2019-01-01 to 2019-09-3076,916USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-07-01 to 2020-09-3015,197USD92
2020-01-01 to 2020-09-3055,906USD274
2019-07-01 to 2019-09-3020,355USD92
2019-01-01 to 2019-09-3061,065USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-07-01 to 2020-09-30-20,611USD92
2020-01-01 to 2020-09-30-75,633USD274
2019-07-01 to 2019-09-30-34,900USD92
2019-01-01 to 2019-09-30-88,362USD273

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2020-01-01 to 2020-09-3011,341USD274
2019-01-01 to 2019-09-3010,589USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2019-01-01 to 2019-09-30760,993USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2020-01-01 to 2020-09-3052,188USD274
2019-01-01 to 2019-09-3069,257USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-1,848,177USD274
2019-01-01 to 2019-09-30-161,943USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-872,971USD274
2019-01-01 to 2019-09-30-2,886,268USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-409,371USD274
2019-01-01 to 2019-09-30-186,823USD273

Inspect the source

Entity
FUSE MEDICAL, INC. / CIK 0000319016
Captured
2026-09-19T11:14:02.031Z
SEC response SHA-256
13d41024642d3becfdbc15fe6e31fdae11d4fa7a32679fcba6c1a612c57d756a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000319016.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))